ArticleJournal of translational medicine2017

Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial.

Darja Karpova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.